Story Cannabis has stopped accepting products tested by a specific Arizona cannabis lab at all 11 of its state locations, according to a recent notice sent to suppliers.
The multi-state operator's decision affects vendors who use the lab for compliance testing, effectively cutting off a distribution channel unless they switch to alternative testing facilities. The move comes after what sources describe as recurring quality control issues with the lab's testing protocols.
"We will no longer be accepting products that have been tested through [the lab] at any of our Story Cannabis locations," a buyer at the company told clients in the notice, according to MJBizDaily's reporting.
Testing Lab Problems in Arizona
Arizona's cannabis testing requirements mandate that all products undergo analysis for potency, pesticides, heavy metals, and microbial contaminants before reaching dispensary shelves. When labs fail to maintain consistent standards, it creates compliance headaches for both retailers and cultivators.
The testing sector has faced scrutiny across multiple states as operators question result accuracy and consistency. Labs compete on price and turnaround time, but retailers ultimately bear responsibility for products sold to consumers.
Story Cannabis operates dispensaries in Phoenix, Tucson, and other Arizona markets. The company has not publicly detailed which specific testing issues prompted the ban or how many vendors it affects.
Industry Impact
For cultivators and manufacturers who relied on the excluded lab, the decision forces a quick pivot. Most Arizona operators maintain relationships with multiple testing facilities to avoid bottlenecks, but switching labs mid-production cycle can delay product launches and affect inventory planning.
Arizona's adult-use market generated $1.4 billion in sales last year, making testing infrastructure a critical component of the supply chain. Any disruption in lab access can ripple through the entire distribution network.
Other MSOs have not announced similar restrictions on the lab's test results, though retailers frequently make independent decisions about vendor requirements and quality standards.
What Happens Next
Vendors working with Story Cannabis now face a choice: find alternative testing or lose access to 11 retail locations in one of the Southwest's largest cannabis markets. Most will likely shift testing to competitors rather than sacrifice the distribution relationship.
The incident highlights ongoing tensions in state-licensed testing systems, where labs operate as private businesses but perform quasi-regulatory functions. When quality issues emerge, retailers have limited recourse beyond refusing to stock affected products.
Story Cannabis has not indicated whether the ban is temporary or permanent, leaving vendors uncertain about future reinstatement possibilities.
This article is based on original reporting by mjbizdaily.com.
